Since the dawn of the 20th century rapid and remarkable changes have been occurring in the field of science. Few of these simple changes have made deep impression in our lives because of the solutions that these scientific innovations provide for the difficult problems that have not been addressed for a long period of time. It is very much possible that the things which are inevitable to us would be obsolete in the new generations to come. New developments will always be there, we don’t need to wonder and be in awe because the majestic curtains will always be open to unveil innovative ideas which are not current, but would be used for future advantages. Few days ago, the Cleveland Clinic made an announcement about the top 10 medical innovations in 2013. How it would affect and the impact it would leave in some of the unresolved medical human conditions will be found out during the coming months and years.
10. Health Care Programs and Its Incentives:
The Bipartisan Medicare Better Health Rewards Program Act of 2012 will privilege the people to maintain stable health conditions with reduced medical expenditures at the same time. It has been tied up with rewards (such as money) for being watchful about their health by alleviating or avoiding complex illnesses and diseases, which can be potential threat to life. Based on this program, financial incentives have been given to improve health at personal level and wellness is assessed by six essential parts of human health including body mass index, blood pressure, cholesterol, diabetes indicators, status of vaccination and use of tobacco products. There are progressive measurements, which will allow recipients to keep themselves healthy and be able to receive monetary rewards up to $400 during second and third year of the program.
9. Tomosynthesis Of Breast:
7. Ex Vivo Lung Perfusion:
Lung transplantation is the treatment of choice for nonmalignant end-stage lung disease in case of failure of all other medical and surgical treatment options. However, the demand for donor lungs exceeds the number of available organs by far, resulting in substantial waiting list mortality. The lung is especially susceptible to damage in donors not only due to its direct external contact, but also due to the development of neurogenic edema and proinflammatory changes caused by brain death. As a consequence of that, lungs are currently used from only 15% of all reported donors. One approach to overcome the scarcity of donor organs is the use of marginal donor lungs. However, there is evidence suggesting an increased incidence of primary graft dysfunction (PGD) in recipients of such marginal organs. The most recent approach to expand the available pool of donor lungs is ex vivo lung perfusion (EVLP). This procedure is performed by perfusing the donor lung outside the body (ex-vivo organ perfusion) on a closed loop circuit simulating the in-vivo scenario, utilizing a specially developed protective perfusion solution (Steen Solution™). It helps the marginal donor lungs to be ready for transplant and eliminate rejection.